Purchase Short-Term Access

Intensive insulin therapy and starch (HES 200/0.5) had some risk and no clear benefit in severe sepsis
Deborah Cook, MD; Lauralyn McIntyre, MD

Annals of Internal Medicine 2008;148:JC4-4. doi:10.7326/0003-4819-148-12-200806170-02004

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.